ABCB1 and hepatocellular carcinoma: In particular, miR-125b overexpression sensitizes HCC cells to doxorubicin and sorafenib treatments, and negatively regulates MDR genes, including ABCC1, ABCG2, and ABCB1, contributing to drug efflux from cancer cells.